SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-19-297694
Filing Date
2019-11-21
Accepted
2019-11-21 17:14:59
Documents
6
Effectiveness Date
2019-11-21

Document Format Files

Seq Description Document Type Size
1 DEFM14A d819924ddefm14a.htm DEFM14A 1616517
2 GRAPHIC g819924g14a03.jpg GRAPHIC 48038
3 GRAPHIC g819924g99e52.jpg GRAPHIC 19326
4 GRAPHIC g819924graa001.jpg GRAPHIC 8855
5 GRAPHIC g819924sp001.jpg GRAPHIC 8791
6 GRAPHIC g819924sp002.jpg GRAPHIC 8831
  Complete submission text file 0001193125-19-297694.txt   1731305
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-33095 | Film No.: 191238068
SIC: 2834 Pharmaceutical Preparations